BRWA
IGC icon

B. Riley Wealth Advisors’s IGC Pharma IGC Stock Holding History

B. Riley Wealth Advisors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-225
Closed -$320 – 1234
2014
Q2 		$320 Buy
+225
New +$254 ﹤0.01% 2377

Other funds holding IGC

Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

B. Riley Wealth Advisors's IGC Position: Q3 2014 in Review

B. Riley Wealth Advisors sold out of IGC Pharma (IGC) in Q3 2014, closing a stake of 225 shares — an estimated $320 sold.

B. Riley Wealth Advisors first reported a position in IGC in Q2 2014 and held it in 1 quarter. The position peaked at $320 in Q2 2014. 5 funds tracked by Wall St. Rank hold IGC as of Q3 2014.

  • B. Riley Wealth Advisors reported no remaining IGC Pharma position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 225 IGC Pharma shares in Q3 2014, an estimated $320.
  • B. Riley Wealth Advisors first reported a position in IGC Pharma in Q2 2014 and held it in 1 quarter.
  • B. Riley Wealth Advisors's IGC Pharma position peaked at $320 in Q2 2014.
  • 5 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2014.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.